GlassScriptPhysician profile
Andres G Sarraga
NPI 1720280563
$20,888.45
in general payments reported to CMS, 2019-2025
26 companies · $2,223 in 2025
The $2,223 reported for 2025 was more than what 85% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $1,290 · 2021: $1,412 · 2022: $2,363 · 2023: $1,947 · 2024: $1,504 · 2025: $2,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,533 · Travel and Lodging: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,532.85 |
| Travel and Lodging | $141.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $9,994.00 | 2019-2022 | |
| Sientra, INC. | $2,589.36 | 2019-2022 | |
| Abbvie INC. | $1,042.00 | 2022-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Integra Lifesciences Corporation | $1,031.40 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Merz North America, INC. | $831.63 | 2019-2024 | Xeomin |
| Revance Therapeutics, INC. | $800.22 | 2024-2025 | Daxxify, Daxi |
| Musculoskeletal Transplant Foundation INC. | $767.98 | 2023-2025 | |
| Galderma Laboratories, L.P. | $617.91 | 2019-2024 | |
| Polynovo North America LLC | $566.49 | 2023-2025 | Novosorb Btm |
| Motiva USA, LLC | $358.06 | 2025 | |
| Tela Bio, INC. | $295.79 | 2020 | |
| Mentor Worldwide LLC | $282.80 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Kerecis Limited | $229.72 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Axogen | $228.59 | 2019-2023 | Avance Nerve Graft |
| Rti Surgical, INC | $219.15 | 2023-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $177.47 | 2022 | |
| Smith+Nephew, INC. | $144.32 | 2025 | Renasys Touch, Pico 14 |
| Pacira Pharmaceuticals Incorporated | $136.80 | 2019 | |
| Endo Pharmaceuticals INC. | $124.99 | 2023 | Xiaflex |
| Medline Industries LP | $124.48 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $103.59 | 2020 | |
| Aroa Biosurgery Incorporated | $86.36 | 2025 | |
| Biotissue Holdings INC. | $63.00 | 2025 | |
| Stryker Corporation | $24.55 | 2019 | |
| Sun Pharmaceutical Industries INC. | $24.40 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $23.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andres Sarraga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.